The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
d -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma
Open accessAbstract
The polarization of tumor-associated macrophages (TAMs) from M2 to M1 phenotype demonstrates great potential for remodeling the immunosuppressive tumor microenvironment (TME) of hepatocellular carcinoma (HCC). d -lactate (DL; a gut microbiome metabolite) acts as an endogenous immunomodulatory agent that enhances Kupffer cells for clearance of pathogens. In this study, the potential of DL for transformation of M2 TAMs to M1 was confirmed, and the mechanisms underlying such polarization were mainly due to the modulation of phosphatidylinositol 3-kinase/protein kinase B pathway. A poly(lactide- co -glycolide) nanoparticle (NP) was used to load DL, and the DL-loaded NP was modified with HCC membrane and M2 macrophage-binding peptide (M2pep), forming a nanoformulation (DL@NP-M-M2pep). DL@NP-M-M2pep transformed M2 TAMs to M1 and remodeled the immunosuppressive TME in HCC mice, promoting the efficacy of anti-CD47 antibody for long-term animal survival. These findings reveal a potential TAM modulatory function of DL and provide a combinatorial strategy for HCC immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 25,486
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812 · cited 1×
“The LC of DL was determined using the D-Lactate Colorimetric Assay Kit (BioVision, USA) as previously described (78), and LC (%) = (the weight of encapsulated drug/the weight of nanoformulation) × 100%.”
MethodTumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
The PI3K Pathway in Human Disease
Fruman, D. A., Chiu, H., Hopkins, B. D., Bagrodia, S., Cantley, L. C., & Abraham, R. T. (2017) · Cell · doi:10.1016/j.cell.2017.07.029 · Cited by 2,749
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Transcriptional regulation of macrophage polarization: enabling diversity with identity
Lawrence, T., & Natoli, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3088 · Cited by 2,284
Bouhlel, M. A., Derudas, B., Rigamonti, E., Dièvart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.010 · Cited by 1,325
Immunology in the liver — from homeostasis to disease
Heymann, F., & Tacke, F. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.200 · Cited by 1,180
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Immune surveillance by the liver
Jenne, C. N., & Kubes, P. (2013) · Nature Immunology · doi:10.1038/ni.2691 · Cited by 1,047
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Chen, Q., Wang, C., Zhang, X., Chen, G., Hu, Q., Li, H., Wang, J., Wen, D., Zhang, Y., Lu, Y., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-018-0319-4 · Cited by 1,010
Self-citationEngineering Macrophages for Cancer Immunotherapy and Drug Delivery
Xia, Y., Rao, L., Yao, H., Wang, Z., Ning, P., & Chen, X. (2020) · Advanced Materials · doi:10.1002/adma.202002054 · Cited by 949
Phagocytosis checkpoints as new targets for cancer immunotherapy
Feng, M., Jiang, W., Kim, B. Y. S., Zhang, C. C., Fu, Y.-X., & Weissman, I. L. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0183-z · Cited by 911
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
Ngambenjawong, C., Gustafson, H. H., & Pun, S. H. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.010 · Cited by 840
CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
Liu, X., Pu, Y., Cron, K., Deng, L., Kline, J., Frazier, W. A., Xu, H., Peng, H., Fu, Y.-X., & Xu, M. M. (2015) · Nature Medicine · doi:10.1038/nm.3931 · Cited by 767
Yang, R., Xu, J., Xu, L., Sun, X., Chen, Q., Zhao, Y., Peng, R., & Liu, Z. (2018) · ACS Nano · doi:10.1021/acsnano.7b09041 · Cited by 698
The gut microbiome and liver cancer: mechanisms and clinical translation
Yu, L.-X., & Schwabe, R. F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.72 · Cited by 634
The interaction of anticancer therapies with tumor-associated macrophages
Mantovani, A., & Allavena, P. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150295 · Cited by 616
Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
Komohara, Y., Fujiwara, Y., Ohnishi, K., & Takeya, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.009 · Cited by 612
Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization
Arranz, A., Doxaki, C., Vergadi, E., Martinez de la Torre, Y., Vaporidi, K., Lagoudaki, E. D., Ieronymaki, E., Androulidaki, A., Venihaki, M., Margioris, A. N., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119038109 · Cited by 608
The CD47‐SIRPα signaling axis as an innate immune checkpoint in cancer
Matlung, H. L., Szilagyi, K., Barclay, N. A., & van den Berg, T. K. (2017) · Immunological Reviews · doi:10.1111/imr.12527 · Cited by 557
Gunassekaran, G. R., Poongkavithai Vadevoo, S. M., Baek, M.-C., & Lee, B. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121137 · Cited by 483
SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy
Veillette, A., & Chen, J. (2018) · Trends in Immunology · doi:10.1016/j.it.2017.12.005 · Cited by 476
Yang, Q., Guo, N., Zhou, Y., Chen, J., Wei, Q., & Han, M. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.04.004 · Cited by 471
Cell membrane-derived nanomaterials for biomedical applications
Fang, R. H., Jiang, Y., Fang, J. C., & Zhang, L. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.041 · Cited by 468
Mouse Models for Cancer Immunotherapy Research
Olson, B., Li, Y., Lin, Y., Liu, E. T., & Patnaik, A. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0044 · Cited by 435
Self-citationYu, Z., Guo, J., Hu, M., Gao, Y., & Huang, L. (2020) · ACS Nano · doi:10.1021/acsnano.0c00708 · Cited by 433
Self-citationCellular backpacks for macrophage immunotherapy
Shields, C. W., Evans, M. A., Wang, L. L.-W., Baugh, N., Iyer, S., Wu, D., Zhao, Z., Pusuluri, A., Ukidve, A., Pan, D. C., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz6579 · Cited by 414
Self-citationRao, L., Wu, L., Liu, Z., Tian, R., Yu, G., Zhou, Z., Yang, K., Xiong, H.-G., Zhang, A., Yu, G.-T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18626-y · Cited by 376
Self-citationGut microbiome in HCC – Mechanisms, diagnosis and therapy
Schwabe, R. F., & Greten, T. F. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.016 · Cited by 363
Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24
Yu, T., Gan, S., Zhu, Q., Dai, D., Li, N., Wang, H., Chen, X., Hou, D., Wang, Y., Pan, Q., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12384-2 · Cited by 348
Self-citationQian, Y., Qiao, S., Dai, Y., Xu, G., Dai, B., Lu, L., Yu, X., Luo, Q., & Zhang, Z. (2017) · ACS Nano · doi:10.1021/acsnano.7b05465 · Cited by 333
Self-citationTargeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival
Cieslewicz, M., Tang, J., Yu, J. L., Cao, H., Zavaljevski, M., Motoyama, K., Lieber, A., Raines, E. W., & Pun, S. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312197110 · Cited by 314
Cell membrane coated-nanoparticles for cancer immunotherapy
Zeng, Y., Li, S., Zhang, S., Wang, L., Yuan, H., & Hu, F. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.023 · Cited by 238
Self-citationLiu, Q., Chen, X., Jia, J., Zhang, W., Yang, T., Wang, L., & Ma, G. (2015) · ACS Nano · doi:10.1021/nn5066793 · Cited by 233
Self-citationToll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K
Troutman, T. D., Bazan, J. F., & Pasare, C. (2012) · Cell Cycle · doi:10.4161/cc.21572 · Cited by 222
Li, M., Li, M., Yang, Y., Liu, Y., Xie, H., Yu, Q., Tian, L., Tang, X., Ren, K., Li, J., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.011 · Cited by 221
Yang, K., Han, W., Jiang, X., Piffko, A., Bugno, J., Han, C., Li, S., Liang, H., Xu, Z., Zheng, W., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-022-01225-x · Cited by 221
Self-citationYang, C., Dou, R., Wei, C., Liu, K., Shi, D., Zhang, C., Liu, Q., Wang, S., & Xiong, B. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.02.006 · Cited by 214
Hu, B., Yu, M., Ma, X., Sun, J., Liu, C., Wang, C., Wu, S., Fu, P., Yang, Z., He, Y., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1022 · Cited by 211
Guo, J., Yu, Z., Das, M., & Huang, L. (2020) · ACS Nano · doi:10.1021/acsnano.0c01676 · Cited by 203
Self-citationSun, D., Zou, Y., Song, L., Han, S., Yang, H., Chu, D., Dai, Y., Ma, J., O'Driscoll, C. M., Yu, Z., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.005 · Cited by 196
Self-citationProgress on Modulating Tumor‐Associated Macrophages with Biomaterials
Sylvestre, M., Crane, C. A., & Pun, S. H. (2020) · Advanced Materials · doi:10.1002/adma.201902007 · Cited by 180
Wang, S., Wu, Q., Chen, T., Su, R., Pan, C., Qian, J., Huang, H., Yin, S., Xie, H., Zhou, L., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.011 · Cited by 168
CD47/SIRPα axis: bridging innate and adaptive immunity
van Duijn, A. V. D. P. , van der Burg, S. H., & Scheeren, F. A. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004589 · Cited by 159
McDonald, B., Zucoloto, A. Z., Yu, I.-L., Burkhard, R., Brown, K., Geuking, M. B., & McCoy, K. D. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.07.014 · Cited by 155
Guo, J., Yu, Z., Sun, D., Zou, Y., Liu, Y., & Huang, L. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01297-0 · Cited by 155
Self-citationWang, J., Zhu, M., & Nie, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113974 · Cited by 153
Yang, H., Song, L., Sun, B., Chu, D., Yang, L., Li, M., Li, H., Dai, Y., Yu, Z., & Guo, J. (2021) · Materials Today Bio · doi:10.1016/j.mtbio.2021.100139 · Cited by 137
Self-citationTumor cell membrane enveloped aluminum phosphate nanoparticles for enhanced cancer vaccination
Gan, J., Du, G., He, C., Jiang, M., Mou, X., Xue, J., & Sun, X. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.008 · Cited by 129
Yu, Z., Li, Y., Li, Y., Zhang, J., Li, M., Ji, L., Tang, Y., Zheng, Y., Sheng, J., Han, Q., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004297 · Cited by 129
Self-citationAnisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice
Guo, J., Ogier, J. R., Desgranges, S., Darcy, R., & O’Driscoll, C. M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.012 · Cited by 127
Self-citationLipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer
Luo, Q., Zheng, N., Jiang, L., Wang, T., Zhang, P., Liu, Y., Zheng, P., Wang, W., Xie, G., Chen, L., et al. (2020) · Cancer Science · doi:10.1111/cas.14616 · Cited by 126
Cao, X., Chen, J., Li, B., Dang, J., Zhang, W., Zhong, X., Wang, C., Raoof, M., Sun, Z., Yu, J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl9171 · Cited by 123
Macrophage Polarization Modulated by NF‐κB in Polylactide Membranes‐Treated Peritendinous Adhesion
Wang, S., Lu, M., Wang, W., Yu, S., Yu, R., Cai, C., Li, Y., Shi, Z., Zou, J., He, M., et al. (2021) · Small · doi:10.1002/smll.202104112 · Cited by 114
Self-citationSa, J. K., Chang, N., Lee, H. W., Cho, H. J., Ceccarelli, M., Cerulo, L., Yin, J., Kim, S. S., Caruso, F. P., Lee, M., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02140-x · Cited by 109
Lv, Y., Liu, M., Zhang, Y. A., Wang, X., Zhang, F., Li, F., Bao, W., Wang, J., Zhang, Y., Wei, W., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b07716 · Cited by 108
Nanomaterials targeting tumor associated macrophages for cancer immunotherapy
Zhao, C., Pang, X., Yang, Z., Wang, S., Deng, H., & Chen, X. S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.028 · Cited by 100
Trivedi, P. J., & Adams, D. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.12.002 · Cited by 99
Tackling TAMs for Cancer Immunotherapy: It’s Nano Time
Yang, Y., Guo, J., & Huang, L. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.08.003 · Cited by 99
Self-citationCao, X., Li, B., Chen, J., Dang, J., Chen, S., Gunes, E. G., Xu, B., Tian, L., Muend, S., Raoof, M., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002022 · Cited by 97
Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy
Guo, J., Zou, Y., & Huang, L. (2023) · Small Methods · doi:10.1002/smtd.202201307 · Cited by 93
Self-citationNanodelivery of cGAS-STING activators for tumor immunotherapy
Guo, J., & Huang, L. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.08.006 · Cited by 84
Self-citationMicrobiome as an immune regulator in health, disease, and therapeutics
Juarez, V. M., Montalbine, A. N., & Singh, A. K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114400 · Cited by 77
The development of small-molecule inhibitors targeting CD47
Yu, W., Ye, Z.-H., Chen, X., Shi, J.-J., & Lu, J. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.11.003 · Cited by 76
Membrane-core nanoparticles for cancer nanomedicine
Guo, J., & Huang, L. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.005 · Cited by 70
Self-citationNgambenjawong, C., Cieslewicz, M., Schellinger, J. G., & Pun, S. H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.057 · Cited by 69
Ji, G., Ma, L., Yao, H., Ma, S., Si, X., Wang, Y., Bao, X., Ma, L., Chen, F., Ma, C., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.09.004 · Cited by 65
Self-citationMechanisms underlying divergent responses of genetically distinct macrophages to IL-4
Hoeksema, M. A., Shen, Z., Holtman, I. R., Zheng, A., Spann, N. J., Cobo, I., Gymrek, M., & Glass, C. K. (2021) · Science Advances · doi:10.1126/sciadv.abf9808 · Cited by 52
Khalife, J., Ghose, J., Martella, M., Viola, D., Rocci, A., Troadec, E., Terrazas, C. A., Satoskar, A. R., Gunes, E. G., Donà, A., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129348 · Cited by 48
Ji, G., Si, X., Dong, S., Xu, Y., Li, M., Yang, B., Tang, Z., Fang, X., Huang, L., Song, W., et al. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c01360 · Cited by 47
Yang, M., Wang, B., Yin, Y., Ma, X., Tang, L., Zhang, Y., Fan, Q., Yin, T., & Wang, Y. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.025 · Cited by 46
Zhou, X., Liu, Y., Hu, M., Wang, M., Liu, X., & Huang, L. (2021) · Science Advances · doi:10.1126/sciadv.abb6596 · Cited by 43
Xu, Y., Wang, Q., Chen, J., Wu, J., Su, J., Gao, W., Chen, W., Shi, S., Wang, S., & Wang, H. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120216 · Cited by 40
Li, M., Beauchemin, H., Popović, N., Peterson, A. C., d'Hennezel, E. B., Piccirillo, C. A., Sun, C., & Polychronakos, C. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.01.009 · Cited by 18
Design and development of benzoxazole derivatives with toll-like receptor 9 antagonism
Roy, S., Mukherjee, A., Paul, B., Rahaman, O., Roy, S., Maithri, G., Ramya, B., Pal, S., Ganguly, D., & Talukdar, A. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.03.086 · Cited by 16
Wang, H., Han, S., Wang, L., Yang, T., Zhang, G., Lian, Y., & Zhao, Y. (2017) · Particuology · doi:10.1016/j.partic.2017.06.008 · Cited by 14
Self-citationZhao, W., Xu, D., Zhang, L., Meng, H., Zheng, Q., & Wang, J. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108548 · Cited by 12
Self-citationStructure based design and synthesis of novel Toll-like Receptor 2 (TLR 2) lipid antagonists
Natala, S. R., Habas, A., Stocking, E. M., Orry, A. J. W., Price, D. L., Gill, M. B., Bonhaus, D. W., Abagyan, R. A., & Wrasidlo, W. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.127861 · Cited by 11
Cited by
Cold and hot tumors: from molecular mechanisms to targeted therapy
Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 682
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Guan, F., Wang, R., Yi, Z., Luo, P., Liu, W., Xie, Y., Liu, Z., Xia, Z., Zhang, H., & Cheng, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02124-y · Cited by 371
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
Tufail, M., Jiang, C.-H., & Li, N. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02280-1 · Cited by 363
Metabolic reprogramming in the tumor microenvironment of liver cancer
Lin, J., Rao, D., Zhang, M., & Gao, Q. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01527-8 · Cited by 251
“Additionally, gut microbiome-derived metabolite D-lactate can shift TAMs from the M2 to M1 phenotype, remodeling the immunosuppressive TME in HCC mice [111, 228].”
BackgroundThe role of tumor-associated macrophages in tumor immune evasion
Huang, R., Kang, T., & Chen, S. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05777-4 · Cited by 230
Metadata
- Authors
- Han, S., Bao, X., Zou, Y., Wang, L., Li, Y., Yang, L., Liao, A., Zhang, X., Jiang, X., Liang, D., Dai, Y., Zheng, Q.-C., Yu, Z., & Guo, J.
- Venue
- Science Advances
- Published
- 2023-07-21
- Volume
- 9
- Issue
- 29
- Pages
- eadg2697-eadg2697
- ISSN
- 2375-2548 (ISSN-L)
- OpenAlex
- W4384820079
- Cited by
- 310
- References
- 80
- FWCI
- 27.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.